Solifenacin Succinate

Product description

Solifenacin is an active substance for the treatment of overactive bladder. It is administered in the form of film-coated tablets.

Comprehensive documentation for drug registration of Solifenacin can be provided by Biesterfeld as referred.

CAS-No.	Regulatory	Monograph
242478-38-2	ASMF	EP, USP

Tradename(s)

Solifenacin Succinate (Antimuscarinic)

Country availability

Available worldwide

Contact person

Marta Ackermann

Sales Manager

This website uses cookies. Those have two functions: On the one hand they are providing basic functionality for this website. On the other hand they allow us to improve our content for you by saving and analyzing anonymized user data. You can redraw your consent to using these cookies at any time. Find more information regarding cookies on our Data Protection Declaration and regarding us on the Imprint.

Mandatory

These cookies are needed for a smooth operation of our website.

Name	Purpose	Lifetime	Type	Provider
CookieConsent	Saves your consent to using cookies.	1 year	HTML	Website
fe_typo_user	Assigns your browser to a session on the server.	session	HTTP	Website
location	stores the users selection of language and country.	1 year	HTML	Website
allow-maps	stores the users selection to allow embedding of google maps.	1 year	HTML	Website

Marketing

With the help of these cookies we strive to improve our offer for our users. By means of anonymized data of website users we can optimize the user flow. This enables us to improve ads and website content.

Name	Purpose	Lifetime	Type	Provider
_ga	Used to distinguish users.	2 years	HTML	Google
_gat	Used to throttle request rate.	1 day	HTML	Google
_gid	Used to distinguish users.	1 day	HTML	Google
_ga_--container-id--	Persists session state.	2 years	HTML	Google
_gac_--property-id--	Contains campaign related information for the user. If you have linked your Google Analytics and Google Ads accounts, Google Ads website conversion tags will read this cookie unless you opt-out.	3 months	HTML	Google